Xcout Intel
Abionic SA
Abionic SA is a medical technology company headquartered in Epalinges and Lausanne, Switzerland, focused on clinical diagnostics and operating its abioSCOPE platform globally.
Subscribe to see Abionic SA’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Abionic SA at a glance
Abionic SA is a medical diagnostics company headquartered in Switzerland. It has raised at least $20M across the 3 funding rounds on record, 1 of them with a disclosed amount. Its most recent funding round, Series C, raised $20M in March 2018. Xcout tracks 2 named people at Abionic SA, including Patrick Pestalozzi (CEO).
Abionic SA leadership
- Patrick PestalozziCEO
- Iwan MärkiCTO and co-founder
Abionic SA funding rounds
At least $20M raised across the 3 rounds on record (1 with a disclosed amount). Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series C | $20M | — | |
| Series B | Undisclosed | — | |
| Series A | Undisclosed | 1 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
Abionic SA competitors
A few of Abionic SA's closest competitors — see the full list of competitors and alternatives →
ABL Diagnostics is a French molecular-diagnostics company that develops in vitro diagnostic assays and bioinformatics software, including solutions for pathogen genotyping, treatment resistance and infectious-disease monitoring. Its products are used by clinical laboratories, hospitals and public-health or research organizations.
Plair SA is headquartered in Geneva, Switzerland, and designs, manufactures, and commercializes advanced laser-based instruments for real-time air microbial detection.
Anbio Biotechnology, established in 2021 and based in Frankfurt am Main, Germany, operates as a global supplier of in vitro diagnostics (IVD) products. The company's international footprint covers regions such as the European Union, Asia Pacific, North America, South America, and Africa. Their product range features various diagnostic solutions, including rapid antigen tests for SARS-CoV-2 (both individual and combined with influenza A/B). Anbio also develops and manufactures products leveraging advanced technologies like lateral flow immunoassay, fluorescence immunoassay, loop-mediated isothermal amplification (LAMP), chemiluminescence immunoassay (CLIA), and reverse-transcription polymerase chain reaction (RT-PCR). These offerings cater to a wide array of markets, including over-the-counter sales, point-of-care testing, and traditional laboratory settings.
Viollier AG is a company founded in 1953 and headquartered in Allschwil, Switzerland. It specializes in diagnostics and operates with a focus on quality and safety.
Axbio is a semiconductor-biotechnology company headquartered in Santa Clara, California. The firm combines semiconductor technology with life sciences to develop products aimed at improving health and safeguarding well-being.
Get Abionic SA's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Abionic SA in Xcout Intel
- 2 named people with titles, LinkedIn and board committees
- 3 funding rounds with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access